CRISPR library Sales


Subscribe Us

By subscription, you consent to allow Ubigene Biosciences to store and process the information provided above to deliver the latest news, research spotlight, and promotions. You can unsubscribe from these communications at anytime.

Location:Home > Promotions > CRISPR library Sales

CRISPR library The preferred and popular tool for gene high-throughput screening The one you can’t miss for gene function study based on phenotype Now over 20 in-stock CRISPR libraries are on sale! Get the library from $199 only Custom CRISPR KO/CRISPRa/CRISPRi library enjoy 35% off! Offering amplification, lentivirus packaging, functional screening, NGS analysis etc One-stop service for the whole process is provided in Ubigene!
This promotion cannot overlap with others.
Ubigene reserves the right to the ultimate interpretation.
Promotion period: 2023.3.20-2023.5.25

Libraries in stockStarting from $199

Coverage rate >99%, Uniformity<10
Genome-wide library 11 types
Species:Human, Mouse, Green Monkey, Pig
Systems:Single/Dual plasmid system A/B
Deliverable:Plasmid (2/100/200/500ug)
Other libraries 10 types
Species:Human, Mouse
Types:Metabolism, Membrane Proteins, Epigenetics, Drug Targets, Kinase Phosphatase, Nucleoprotein, etc

Customized Libraries35% off

CRISPR KO/CRISPRa/CRISPRi Coverage rate >99%, Uniformity<10 Supported by parameters for 200+ cell lines
CRISPR library construction 100ug Plasimid NGS analysis report
Library amplification Different sizes for plasimid deliverables Optional NGS analysis
Lentivirus Packaging 1mL or 5mL 1*10^8TU/mL
Functional Screening & NGS Analysis Cell pool available NGS gene function screening report

Technical Process

Samples for Data in the NGS report

Contact us

* How would you like us to contact you?
How did you hear about us:
 Google search
 Recommendations from others
 Social media
Our Solution Specialists will contact you within 2 business days. Of course, you can also tell us when you would like to be contacted:

Our Solution Specialists will contact you as soon as possible!

Ubigene reserves the right to the ultimate interpretation.

Contact us